// App-Quantinova.ai

: Bay 94-9027 Can be Accurately Measured across Regions with Appropriate One-Stage Assay Reagent Use

Researchers

Presenter

  • Rajiv K. Pruthi

Principal Investigators

  • Donna D. Castellone

  • Nikki Church

  • Lilley Leong

  • Steve Kitchen

Medical Centers

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

  • Specialty Testing and Special Coagulation and Hematology, New York Presbyterian-Columbia University Medical Center, New York, NY

  • Bayer AG, Whippany, NJ

  • Bayer, San Francisco

  • Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Antihemophilic factor

  • BAY 94-9027

  • rAHF-PFM

  • rFVIII

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved